Cardiovascular actions of berberine
Abstract
Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants. It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea. This manuscript describes cardiovascular effects of berberine and its derivatives, tetrahydroberberine and 8-oxoberberine. Berberine has positive inotropic, negative chronotropic, antiarrhythmic, and vasodilator properties. Both derivatives of berberine have antiarrhythmic activity. Some cardiovascular effects of berberine and its derivatives are attributed to the blockade of K+ channels (delayed rectifier and K(ATP)) and stimulation of Na+ -Ca(2+) exchanger. Berberine has been shown to prolong the duration of ventricular action potential. Its vasodilator activity has been attributed to multiple cellular mechanisms. The cardiovascular effects of berberine suggest its possible clinical usefulness in the treatment of arrhythmias and/or heart failure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Berberine's vasodilatory and bradycardic effects can potentiate the hypotension and bradycardia induced by antihypertensives and beta-blockers.
“Vasodilatory and bradycardic effects can potentiate the hypotension and bradycardia induced by antihypertensives and beta-blockers [40,87]”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [87]
Cites
Berberine sulfate: antimicrobial activity, bioassay, and mode of action
Amin, A., Subbaiah, T. V., & Abbasi, K. M. (1969) · Canadian Journal of Microbiology · doi:10.1139/m69-190 · Cited by 299 · see citing works
Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00162-7 · Cited by 270 · see citing works
(2020) · Elsevier eBooks · doi:10.1016/c2015-0-02243-2 · Cited by 264 · see citing works
Berberine: Therapeutic Potential of an Alkaloid Found in Several Medicinal Plants
Birdsall, T. C., & Kelly, G. S. (1997) · Alternative medicine review · Cited by 258 · see citing works
Delayed afterdepolarizations in heart muscle: mechanisms and relevance.
January, C. T., & Fozzard, H. A. (1988) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00019-5 · Cited by 166 · see citing works
Eisner, D. A., LEDERER, W. J., & Vaughan‐Jones, R. D. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014560 · Cited by 130 · see citing works
Cardiovascular effects of berberine in patients with severe congestive heart failure
Marin ‐ NETO, J. A., Maciel, B. C., Secches, A. L., & Gallo, L. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110411 · Cited by 128 · see citing works
Vasorelaxant and antiproliferative effects of berberine
Ko, W. H., Yao, X., Lau, C., Law, W.-I., Chen, Z., Kwok, W., Ho, W. K. K., & Huang, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00339-3 · Cited by 121 · see citing works
Self-citationMonoamine Oxidase Inhibitors from Rhizoma of Coptis chinensis
Kong, L. D., Cheng, C. H. K., & Tan, R. X. (2001) · Planta Medica · doi:10.1055/s-2001-10874 · Cited by 110 · see citing works
Nakaya, H., Takeda, Y., Tohse, N., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12294.x · Cited by 91 · see citing works
CARDIAC ELECTROPHYSIOLOGY: A TEXTBOOK
Singer, I. (1991) · CHEST Journal · doi:10.1016/s0012-3692(16)52766-4 · Cited by 88 · see citing works
Zeng, X., & Zeng, X. (1999) · Biomedical Chromatography · doi:10.1002/(sici)1099-0801(199911)13:7 · Cited by 84 · see citing works
Mechanism of vasodilatory effect of berberine in rat mesenteric artery
Chiou, W., Yen, M., & Chieh-Fu, C. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90832-b · Cited by 74 · see citing works
Nishino, H., Kitagawa, K., Fujiki, H., et al. (2009) · Oncology · doi:10.1159/000226349 · Cited by 73 · see citing works
YAMAMOTO, K., TAKASE, H., Ken-ichi, A. B. E., Saito, Y., & SUZUKI, A. (1993) · Folia Pharmacologica Japonica · doi:10.1254/fpj.101.3_169 · Cited by 71 · see citing works
A biochemical study on the hypotensive effect of berberine in rats
Chun, Y. T., Yip, T. T., Lau, K. L., Kong, Y. C., & Sankawa, U. (1979) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(79)90085-5 · Cited by 59 · see citing works
Bova, S., Padrini, R., Goldman, W. F., Berman, D. M., & Cargnelli, G. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10978-6 · Cited by 56 · see citing works
Study of some pharmacological actions of berberine.
Sabir, M., & Nk, B. (1971) · PubMed · Cited by 49 · see citing works
Liu, J., Chan, P., Chen, Y., Tomlinson, B., Hong, S.-F., & Cheng, J. (1999) · Pharmacology · doi:10.1159/000028331 · Cited by 46 · see citing works
Neto, F. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12836.x · Cited by 45 · see citing works
Ionic Mechanism Responsible for Prolongation of Cardiac Action-Potential Duration by Berberine
Wang, Y.-X., & Zheng, Y. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199708000-00010 · Cited by 45 · see citing works
Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit
Chiou, W., Chen, J., & Chen, C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702249 · Cited by 43 · see citing works
Sánchez‐Chapula, J. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15302.x · Cited by 42 · see citing works
Effects of Berberine on Delayed Afterdepolarizations in Ventricular Muscles In Vitro and In Vivo
Wang, Y.-X., Yao, X. J., & Tan, Y.-H. (1994) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199405000-00005 · Cited by 41 · see citing works
Self-citationInotropic and Chronotropic Activity of Berberine on Isolated Guinea Pig Atria
Shaffer, J. E. (1985) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198503000-00016 · Cited by 40 · see citing works
Cohen, H. G., Seifen, E. E., Straub, K. D., et al. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90325-8 · Cited by 37 · see citing works
Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum.
Tsai, C., & Ochillo, R. F. (1992) · PubMed · Cited by 35 · see citing works
Inhibitory effects of berberine on ATP-sensitive K+ channels in cardiac myocytes
Wang, Y.-X., Zheng, Y., & Zhou, X.-B. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00663-2 · Cited by 33 · see citing works
Mechanical and electrophysiological effects of 8‐oxoberberine (JKL1073A) on atrial tissue
Chi, J., Chu, S., Lee, C., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15431.x · Cited by 27 · see citing works
Effects of berberine of L- and T-type calcium channels in guinea pig ventricular myocytes.
Xu, S., Zhang, Y., Ren, J. Y., et al. (1997) · PubMed · Cited by 27 · see citing works
Mechanism of the Aortic Relaxation Induced by Low Concentrations of Berberine
Wong, K. (1998) · Planta Medica · doi:10.1055/s-2006-957575 · Cited by 26 · see citing works
Dicentrine, an ?-adrenoceptor antagonist with sodium and potassium channel blocking activities
Su, M., Nieh, Y.-C., Huang, H.-C., et al. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178204 · Cited by 24 · see citing works
Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs.
Ölmez, E., & Ilhan, M. (1992) · PubMed · Cited by 24 · see citing works
Huang, W., Yan, H., Jin, J., Yu, C., & Zhang, H. (1992) · PubMed · Cited by 23 · see citing works
Some Observations on the Cardiovascular Effects of 9-Substituted Berberines
Fukuda, H., Watanabe, K., & Kudo, Y. (1970) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.18.1299 · Cited by 21 · see citing works
PHARMACOLOGICAL INVESTIGATIONS OF BERBERINE SULPHATE
Kulkarni, S. K., Dandiya, P. C., & VARANDANI, N. L. (1972) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.22.11 · Cited by 17 · see citing works
Wu, J., & Liu, T. P. (1995) · PubMed · Cited by 17 · see citing works
THE ACTION OF BERBERINE ON MAMMALIAN HEARTS
JANG, C. S. (1941) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03380-4 · Cited by 11 · see citing works
Effects of 8-oxoberberine on sodium current in rat ventricular and human atrial myocytes.
Chi, J. F., Chu, S., Lee, C. S., et al. (1997) · PubMed · Cited by 10 · see citing works
Influence of berberine on the blood pressure of rabbits
Ko, S.-T., & Lim, D. Y. (1980) · Archives of Pharmacal Research · doi:10.1007/bf02884757 · Cited by 9 · see citing works
Ko, F., Chang, Y., Chen, C. A., et al. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05986.x · Cited by 9 · see citing works
Yang, S., Miao, Y., Han, Q., et al. (1993) · PubMed · Cited by 9 · see citing works
Effects of tetrahydroberberine on ischemic and reperfused myocardium in rats.
Zhou, J., XUAN, B., & Li, D. (1993) · PubMed · Cited by 7 · see citing works
Xu, Z. F., Cao, H.-Y., & Li, Q. (1989) · PubMed · Cited by 7 · see citing works
[The role and mechanism of berberine on coronary arteries].
Huang, W. (1990) · PubMed · Cited by 5 · see citing works
Kimura, M., Waki, I., & Kimura, I. (1978) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.1.145 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391 · see citing works
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465 · see citing works
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363 · see citing works
Derosa, G., Maffioli, P., & Cicero, A. F. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.704014 · Cited by 171 · see citing works
Rodriguez-Menchaca, A., Ferrer-Villada, T., Lara, J., Fernandez, D., Navarro-Polanco, R. A., & Sanchez-Chapula, J. A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000191564.52242.00 · Cited by 39 · see citing works
Quasi-Irreversible Inhibition of CYP2D6 by Berberine
Kim, H. G., Lee, H. S., Jeon, J. S., Choi, Y. J., Choi, Y. J., Yoo, S.-Y., Kim, E.-Y., Lee, K., Park, I., Na, M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100916 · Cited by 21 · see citing works
Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2 · see citing works
“…drugs hERG block + metabolic inhibition [40] ↑ long-QT/torsades de pointes risk D plus case reports—in vitro mechanism and published cases [40,84,90] Antihypertensives/beta-blockers Hemodynamic additivity [87] ↑ hypotension/bradycardia B—clinical, pharmacodynamic endpoint [87,88] Table 3.”
- Authors
- Lau, C., Yao, X., Chen, Z., Ko, W., & Huang, Y.
- Affiliations
- Chinese University of Hong Kong (HK)
- Venue
- Cardiovascular Drug Reviews
- Publisher
- Wiley
- Published
- 2001-09
- Volume
- 19
- Issue
- 3
- Pages
- 234-244
- ISSN
- 0897-5957 (ISSN-L)
- 1527-3466
- OpenAlex
- W2015973798
- Cited by
- 281
- References
- 46
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 11 · 2023: 11 · 2022: 17 · 2021: 13 · 2020: 19 · 2019: 9 · 2018: 12 · 2017: 22 · 2016: 9 · 2015: 20 · 2014: 11 · 2013: 17 · 2012: 10
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Drug Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Analysis
- Keywords
- berberine, cardiovascular effects, tetrahydroberberine, antiarrhythmic activity, positive inotropic effect, negative chronotropic effect, vasodilation, potassium channel blockade, delayed rectifier potassium channel, ATP-sensitive potassium channels, Na+/Ca2+ exchanger, ventricular action potential duration, heart failure, cardiac arrhythmias, Hydrastis canadensis, traditional Chinese medicine
- MeSH terms
- Animals, Anti-Arrhythmia Agents, Berberine, Cardiotonic Agents, Cardiovascular Agents, Heart Rate, Hemodynamics, Humans, Plants, Medicinal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review